It’s important to note that obesity itself isn’t an indicator of one’s health, but there are cases, like this one, when it ...

It’s important to note that obesity itself isn’t an indicator of one’s health, but there are cases, like this one, when it ...

Earlier this year, we reported that breast cancer, colorectal cancer, and kidney cancer are all on the rise in the U.S. There ...

Objectives Endometrial cancer (EC) incidence has been rising globally, while mortality has remained stable, particularly in Nordic countries. This study aimed to explore the role of transvaginal ...

Endometrial thickness is measured with a transvaginal ultrasound. You might receive an ultrasound to screen for cancer if you experience bleeding, but the American College of Obstetricians and ...

About 69,000 new cases and nearly 14,000 deaths are expected this year, according to the American Cancer Society.

Uterine cancer projected to rise in US by 2050, Black women likely to be hit hardest The projections come as data shows increases in uterine cancer cases and deaths.

Key takeaways: Both incidence and mortality rates for uterine cancer are expected to increase through 2050. Black women will experience disproportionate increases compared with white women.

Galesburg family launches cancer-awareness website The site was started after the family of Sherina Anderson felt the need to shed more light for caregivers to navigate through the tough times.

Rina-S led to a 50% response rate, including two complete responses, in heavily pretreated advanced endometrial cancer, according to early trial findings.

Background: Endometrial cancer, the most prevalent gynecological malignancy, presents a significant public health concern, with disparities in incidence, treatment, and survival outcomes reflecting ...

Genmab has shared the first data on rinatabart sesutecan (Rina-S) in advanced endometrial cancer. The biotech reported a 50% unconfirmed response rate, beating the expectations of William Blair ...